The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 987.00
Bid: 991.60
Ask: 991.80
Change: -4.60 (-0.46%)
Spread: 0.20 (0.02%)
Open: 994.60
High: 995.00
Low: 965.80
Prev. Close: 991.60
PSON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Disposal

18 Dec 2019 07:00

RNS Number : 2420X
Pearson PLC
18 December 2019
 

Pearson agrees to sell remaining 25% stake in Penguin Random House to Bertelsmann, generating net proceeds of approximately $675m (£530m1), and announces a return of £350m to shareholders through a share buyback.

18th December 2019

 

Pearson, the world's learning company, today announces an agreement to sell its remaining 25% stake in Penguin Random House to partner Bertelsmann SE & Co KGaA ("Bertelsmann") for a consideration of approximately $675m / (£530m). The transaction is in line with Pearson's simplification strategy.

 

This transaction values the Penguin Random House venture at an enterprise value of $3.67bn, compared with the $3.55bn enterprise valuation in 2017 when Pearson sold a 22% stake in the joint venture.

 

The disposal is subject to regulatory consent and is expected to close in the first half of 2020 and therefore will have no impact on 2019 results. Pearson is committed to its disciplined approach to capital allocation and in early 2020 will commence a return of capital to shareholders through a £350m share buyback. Shares repurchased will be cancelled. The remainder of the proceeds will be used for general corporate purposes.

 

The formation of Penguin Random House in 2013 created the first truly global consumer book publishing company, with a significant market presence, generating synergies through the integration process and creating significant shareholder value. Our stake2 in Penguin Random House will have generated c.£1.9bn in net disposal proceeds and dividends.

 

Pearson owns 25% of the Penguin Random House venture which in 2018 reported revenue of $3,703m and EBIT of $467m as reported in € converted at a 2018 average €/$ exchange rate of 1.18, gross assets of $4,407m and net assets of $1,166m converted at a 2018 closing €/$ rate of 1.15. In 2018, Pearson's 25% associate share in the venture contributed £68m after tax to its adjusted operating profit.

 

John Fallon, Pearson's chief executive, said: "For almost 50 years, Pearson has been proud to play our part in the publishing and commercial success of first Penguin and then more recently Penguin Random House. With the sale of our remaining stake to our partners, Bertelsmann, we know the company is in good hands - and we wish our colleagues and authors every future success. This enables Pearson now to be completely focused on building the world's leading digital learning company, linking education to employability and skills, and reaching more learners around the world to support them through a lifetime of learning."

 

Notes:

1 Based on guidance $/£ exchange rates of 1.27.

2 47% stake held between 1st July 2013 and 5th October 2017, 25% stake held from 6th October 2017.

 

For more information

T + 44 (0)20 7010 2310

Investors: Jo Russell, Anjali Kotak

Press: Tom Steiner, Gemma Terry

 

This announcement contains inside information

 

Ends

 

Forward looking statements:

Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated cost savings and synergies and the execution of Pearson's strategy, are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future. There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly-filed documents and you are advised to read, in particular, te risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (www.pearson.com/investors). Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DISEAEAPFFPNFEF
Date   Source Headline
26th Apr 20241:31 pmRNSResult of AGM
26th Apr 20247:00 amRNSPearson 2024 Q1 Trading Update
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20243:59 pmRNSDirector/PDMR Shareholding
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20246:30 pmRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20244:00 pmRNSDirector/PDMR Shareholding
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20247:15 amRNSDirector/PDMR Shareholding
2nd Apr 20247:00 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:10 amRNSNotice of AGM
22nd Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20241:12 pmRNSAnnual Financial Report
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares
11th Mar 20247:00 amRNSTransaction in Own Shares
8th Mar 20247:00 amRNSTransaction in Own Shares
7th Mar 20247:00 amRNSTransaction in Own Shares
6th Mar 20247:00 amRNSTransaction in Own Shares
5th Mar 20247:00 amRNSTransaction in Own Shares
4th Mar 20247:00 amRNSTransaction in Own Shares
1st Mar 20249:00 amRNSTotal Voting Rights
1st Mar 20248:37 amRNSBoard & Committee changes
1st Mar 20248:29 amRNSAnnouncement of share repurchase programme
1st Mar 20247:00 amRNSPearson 2023 Preliminary Results
1st Mar 20247:00 amRNSTransaction in Own Shares
28th Feb 20246:19 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.